Home › Companies › DAY ONE BIOPHARMACEUTICALS INC. › 2023-2024
Compiled from SEC Form N-PX filings and DAY ONE BIOPHARMACEUTICALS INC.’s Form 8-K, filed 2024-05-24 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Proxy season: 2023-2024 2024-2025
Explore DAY ONE BIOPHARMACEUTICALS INC. in the interactive database Compare manager voting policies
These tallies are DAY ONE BIOPHARMACEUTICALS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-05-24 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Jeremy Bender, Ph.D., M.B.A. | 62,935,239 | -- | -- | 11,080,216 | 4,390,159 | Majority: yes |
| Elect Director: Habib Dable, M.B.A. | 73,883,045 | -- | -- | 132,410 | 4,390,159 | Majority: yes |
| Elect Director: Saira Ramasastry, M.S., M.Phil. | 59,183,371 | -- | -- | 14,832,084 | 4,390,159 | Majority: yes |
| 2. The ratification of appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2024. | 78,312,286 | 91,361 | 1,967 | -- | -- | Majority: yes |
| 3. The approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers. | 73,212,768 | 612,128 | 190,559 | -- | 4,390,159 | Majority: yes |
Source: DAY ONE BIOPHARMACEUTICALS INC., Form 8-K, filed with the SEC on 2024-05-24 — read the filing on EDGAR.
Each item below shows how the 175 asset managers that disclosed a DAY ONE BIOPHARMACEUTICALS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of DAY ONE BIOPHARMACEUTICALS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 6 wordings of this item as funds reported it.
99.1% Majority: yes · of votes cast
DAY ONE BIOPHARMACEUTICALS INC.’s own tally for this item (“3. The approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers.”): 73,212,768 for, 612,128 against, per its Form 8-K filed 2024-05-24 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 87,389,859 outstanding shares: 84% for, 0.8% against (84% of the company cast a for/against vote).
The 174 asset managers below cast 99.5% of the shares they voted on this item FOR (71,127,337 for, 327,410 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| New York Life | 14,016,264 | 0 | 0 | 0 | For |
| RA CAPITAL MANAGEMENT, L.P. | 7,747,198 | 0 | 0 | 0 | For |
| Fidelity | 4,784,525 | 0 | 0 | 0 | For |
| Vanguard | 4,771,360 | 0 | 0 | 0 | For |
| BlackRock | 4,273,779 | 0 | 0 | 0 | For |
| T. Rowe Price | 4,001,708 | 0 | 0 | 0 | For |
| FRANKLIN ADVISERS INC | 3,732,355 | 0 | 0 | 0 | For |
| State Street | 3,713,225 | 0 | 0 | 0 | For |
| VIKING GLOBAL INVESTORS LP | 2,558,563 | 0 | 0 | 0 | For |
| PICTET ASSET MANAGEMENT SA | 2,157,178 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 2,039,003 | 0 | 0 | 0 | For |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,765,009 | 0 | 0 | 0 | For |
| BRAIDWELL LP | 1,485,862 | 0 | 0 | 0 | For |
| TimesSquare Capital Management, LLC | 1,411,807 | 0 | 0 | 0 | For |
| Atlas Venture Life Science Advisors, LLC | 1,371,131 | 0 | 0 | 0 | For |
| Janus Henderson | 1,268,095 | 0 | 0 | 0 | For |
| Polar Capital Holdings Plc | 1,169,829 | 0 | 0 | 0 | For |
| Charles Schwab | 915,294 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 906,020 | 0 | 0 | 0 | For |
| Dimensional | 699,533 | 0 | 0 | 0 | For |
| MAVERICK CAPITAL LTD | 643,388 | 0 | 0 | 0 | For |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 461,188 | 0 | 0 | 0 | For |
| Northern Trust | 337,555 | 52 | 0 | 0 | For |
| Candriam S.C.A. | 290,000 | 0 | 0 | 0 | For |
| Wellington | 242,679 | 0 | 0 | 0 | For |
Showing the 25 largest of 174 asset managers. See all 174 in the interactive database.
Combines 4 wordings of this item as funds reported it.
100% fund support · no official result
The 169 asset managers below cast 100% of the shares they voted on this item FOR (89,875 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| New York Life | 0 | 0 | 0 | 0 | One Year |
| RA CAPITAL MANAGEMENT, L.P. | 0 | 0 | 7,747,198 | 0 | Abstain |
| Fidelity | 0 | 0 | 0 | 0 | One Year |
| Vanguard | 0 | 0 | 0 | 0 | One Year |
| BlackRock | 0 | 0 | 0 | 0 | One Year |
| T. Rowe Price | 0 | 0 | 0 | 0 | One Year |
| FRANKLIN ADVISERS INC | 0 | 0 | 0 | 0 | One Year |
| State Street | 0 | 0 | 0 | 0 | One Year |
| VIKING GLOBAL INVESTORS LP | 0 | 0 | 0 | 0 | One Year |
| PICTET ASSET MANAGEMENT SA | 0 | 0 | 0 | 0 | One Year |
| FRANKLIN STRATEGIC SERIES | 0 | 0 | 0 | 0 | One Year |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 0 | 0 | 0 | 0 | 1 Year |
| BRAIDWELL LP | 0 | 0 | 0 | 0 | One Year |
| TimesSquare Capital Management, LLC | 0 | 0 | 0 | 0 | One Year |
| Atlas Venture Life Science Advisors, LLC | 0 | 0 | 0 | 0 | 1 Year |
| Janus Henderson | 0 | 0 | 0 | 0 | One Year |
| Polar Capital Holdings Plc | 0 | 0 | 0 | 0 | One Year |
| Charles Schwab | 0 | 0 | 0 | 0 | 1 Year |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | One Year |
| Dimensional | 0 | 0 | 0 | 0 | Three Years |
| MAVERICK CAPITAL LTD | 0 | 0 | 0 | 0 | 1 Year |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 0 | 0 | 0 | 0 | One Year |
| Northern Trust | 0 | 0 | 0 | 0 | 1 Year |
| Candriam S.C.A. | 0 | 0 | 0 | 0 | One Year |
| Wellington | 0 | 0 | 0 | 0 | 1 Year |
Showing the 25 largest of 169 asset managers. See all 169 in the interactive database.
Combines 4 wordings of this item as funds reported it.
99.8% Majority: yes · of votes cast
DAY ONE BIOPHARMACEUTICALS INC.’s own tally for this item (“2. The ratification of appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2024.”): 78,312,286 for, 91,361 against, per its Form 8-K filed 2024-05-24 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 87,389,859 outstanding shares: 90% for, 0.2% against (90% of the company cast a for/against vote).
The 59 asset managers below cast 100% of the shares they voted on this item FOR (18,616,897 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,623,302 | 0 | 0 | 0 | For |
| BlackRock | 2,654,524 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 2,039,003 | 0 | 0 | 0 | For |
| Fidelity | 1,777,196 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,751,257 | 0 | 0 | 0 | For |
| TimesSquare Capital Management, LLC | 1,411,807 | 0 | 0 | 0 | For |
| State Street | 1,350,725 | 0 | 0 | 0 | For |
| Dimensional | 602,169 | 0 | 0 | 0 | For |
| Charles Schwab | 457,642 | 0 | 0 | 0 | For |
| Equitable | 175,282 | 0 | 0 | 0 | For |
| Simplify Exchange Traded Funds | 175,018 | 0 | 0 | 0 | For |
| TIAA | 151,563 | 0 | 0 | 0 | For |
| AMG FUNDS | 137,900 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 131,714 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 111,530 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 110,000 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 91,858 | 0 | 0 | 0 | For |
| Lincoln Financial | 84,613 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 64,717 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 61,631 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 57,714 | 0 | 0 | 0 | For |
| ProShares | 45,154 | 0 | 0 | 0 | For |
| Tema ETF Trust | 44,423 | 0 | 0 | 0 | For |
| Brighthouse | 42,043 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 34,923 | 0 | 0 | 0 | For |
Showing the 25 largest of 59 asset managers. See all 59 in the interactive database.
Combines 4 wordings of this item as funds reported it.
99.8% Majority: yes · of votes cast
DAY ONE BIOPHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Habib Dable, M.B.A.”): 73,883,045 for, 132,410 withheld, per its Form 8-K filed 2024-05-24 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 87,389,859 outstanding shares: 85% for, 0.2% withheld (85% of the company cast a for/withheld vote).
The 58 asset managers below cast 100% of the shares they voted on this item FOR (18,441,879 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,623,302 | 0 | 0 | 0 | For |
| BlackRock | 2,654,524 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 2,039,003 | 0 | 0 | 0 | For |
| Fidelity | 1,777,196 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,751,257 | 0 | 0 | 0 | For |
| TimesSquare Capital Management, LLC | 1,411,807 | 0 | 0 | 0 | For |
| State Street | 1,350,725 | 0 | 0 | 0 | For |
| Dimensional | 602,169 | 0 | 0 | 0 | For |
| Charles Schwab | 457,642 | 0 | 0 | 0 | For |
| Equitable | 175,282 | 0 | 0 | 0 | For |
| TIAA | 151,563 | 0 | 0 | 0 | For |
| AMG FUNDS | 137,900 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 131,714 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 111,530 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 110,000 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 91,858 | 0 | 0 | 0 | For |
| Lincoln Financial | 84,613 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 64,717 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 61,631 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 57,714 | 0 | 0 | 0 | For |
| ProShares | 45,154 | 0 | 0 | 0 | For |
| Tema ETF Trust | 44,423 | 0 | 0 | 0 | For |
| Brighthouse | 42,043 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 34,923 | 0 | 0 | 0 | For |
| Northern Trust | 34,181 | 0 | 0 | 0 | For |
Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.
Combines 4 wordings of this item as funds reported it.
85% Majority: yes · of votes cast
DAY ONE BIOPHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Jeremy Bender, Ph.D., M.B.A.”): 62,935,239 for, 11,080,216 withheld, per its Form 8-K filed 2024-05-24 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 87,389,859 outstanding shares: 72% for, 13% withheld (85% of the company cast a for/withheld vote).
The 58 asset managers below cast 100% of the shares they voted on this item FOR (17,095,619 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,623,302 | 0 | 0 | 0 | For |
| BlackRock | 2,654,524 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 2,039,003 | 0 | 0 | 0 | For |
| Fidelity | 1,777,196 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,751,257 | 0 | 0 | 0 | For |
| TimesSquare Capital Management, LLC | 1,411,807 | 0 | 0 | 0 | For |
| State Street | 1,348,881 | 0 | 1,844 | 0 | For |
| Dimensional | 0 | 0 | 602,169 | 0 | Abstain |
| Charles Schwab | 457,642 | 0 | 0 | 0 | For |
| Equitable | 175,282 | 0 | 0 | 0 | For |
| TIAA | 151,563 | 0 | 0 | 0 | For |
| AMG FUNDS | 137,900 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 0 | 0 | 131,714 | 0 | Abstain |
| QUANTITATIVE MASTER SERIES LLC | 111,530 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 0 | 0 | 110,000 | 0 | Abstain |
| DRIEHAUS MUTUAL FUNDS | 0 | 0 | 91,858 | 0 | Abstain |
| Lincoln Financial | 51,700 | 0 | 32,913 | 0 | For |
| RBB FUND, INC. | 13,255 | 0 | 51,462 | 0 | Abstain |
| ALPS ETF Trust | 0 | 0 | 61,631 | 0 | Abstain |
| Advisors' Inner Circle Fund III | 57,536 | 0 | 178 | 0 | For |
| ProShares | 0 | 0 | 45,154 | 0 | Abstain |
| Tema ETF Trust | 44,423 | 0 | 0 | 0 | For |
| Brighthouse | 21,771 | 0 | 20,272 | 0 | For |
| Brinker Capital Destinations Trust | 2,218 | 0 | 32,705 | 0 | Abstain |
| Northern Trust | 34,181 | 0 | 0 | 0 | For |
Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.
Combines 4 wordings of this item as funds reported it.
80% Majority: yes · of votes cast
DAY ONE BIOPHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Saira Ramasastry, M.S., M.Phil.”): 59,183,371 for, 14,832,084 withheld, per its Form 8-K filed 2024-05-24 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 87,389,859 outstanding shares: 68% for, 17% withheld (85% of the company cast a for/withheld vote).
The 58 asset managers below cast 100% of the shares they voted on this item FOR (15,622,416 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,623,302 | 0 | 0 | 0 | For |
| BlackRock | 2,654,524 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 2,039,003 | 0 | 0 | 0 | For |
| Fidelity | 1,777,196 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,751,257 | 0 | 0 | 0 | For |
| TimesSquare Capital Management, LLC | 1,411,807 | 0 | 0 | 0 | For |
| State Street | 1,350 | 0 | 1,349,375 | 0 | Abstain |
| Dimensional | 0 | 0 | 602,169 | 0 | Abstain |
| Charles Schwab | 457,642 | 0 | 0 | 0 | For |
| Equitable | 112,282 | 0 | 63,000 | 0 | For |
| TIAA | 151,563 | 0 | 0 | 0 | For |
| AMG FUNDS | 137,900 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 0 | 0 | 131,714 | 0 | Abstain |
| QUANTITATIVE MASTER SERIES LLC | 111,530 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 0 | 0 | 110,000 | 0 | Abstain |
| DRIEHAUS MUTUAL FUNDS | 0 | 0 | 91,858 | 0 | Abstain |
| Lincoln Financial | 0 | 0 | 84,613 | 0 | Abstain |
| RBB FUND, INC. | 13,255 | 0 | 51,462 | 0 | Abstain |
| ALPS ETF Trust | 0 | 0 | 61,631 | 0 | Abstain |
| Advisors' Inner Circle Fund III | 57,714 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 45,154 | 0 | Abstain |
| Tema ETF Trust | 44,423 | 0 | 0 | 0 | For |
| Brighthouse | 21,771 | 0 | 20,272 | 0 | For |
| Brinker Capital Destinations Trust | 0 | 0 | 34,923 | 0 | Abstain |
| Northern Trust | 34,181 | 0 | 0 | 0 | For |
Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.
— fund support · no official result
No shares were cast for or against this item by the managers below — every disclosed position was an abstention or was not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 0 | 0 | 0 | 0 | 1-Year |
| JPMorgan | 0 | 0 | 0 | 0 | One Year |
| Desjardins Global Asset Management Inc. | 0 | 0 | 0 | 0 | One Year |
Ranked by the number of DAY ONE BIOPHARMACEUTICALS INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 87,389,859 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | New York Life | 16.04% |
| 2 | RA CAPITAL MANAGEMENT, L.P. | 8.87% |
| 3 | Fidelity | 5.47% |
| 4 | Vanguard | 5.46% |
| 5 | BlackRock | 4.89% |
| 6 | T. Rowe Price | 4.58% |
| 7 | FRANKLIN ADVISERS INC | 4.27% |
| 8 | State Street | 4.25% |
| 9 | VIKING GLOBAL INVESTORS LP | 2.93% |
| 10 | PICTET ASSET MANAGEMENT SA | 2.47% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| AI Day 1 LLC | 14.79% | DEF14A |
| FMR (Fidelity) | 11.55% | 13F |
| BlackRock | 10.30% | 13F |
| RA Capital Management, L.P. | 8.94% | DEF14A |
| Entities affiliated with Atlas Venture | 8.71% | DEF14A |
| Vanguard Group | 7.07% | 13F |
| Franklin Templeton | 4.36% | 13F |
| Jeremy Bender, Ph.D., M.B.A. | 3.65% | DEF14A |
| State Street | 3.31% | 13F |
| Samuel Blackman, M.D., Ph.D. | 2.81% | DEF14A |
Percentages above are of 87,389,859 shares outstanding, as reported by DAY ONE BIOPHARMACEUTICALS INC. on its Form 10-Q dated 2024-05-01 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from DAY ONE BIOPHARMACEUTICALS INC.’s 10-Q dated 2024-05-01. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At DAY ONE BIOPHARMACEUTICALS INC.'s shareholder meeting held 2024-05-23, in the 2023-2024 proxy season, 175 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,568 separate fund positions. Their filings are grouped here into 7 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Approval, on a non-binding advisory basis, of the compensation of our named executive officers. — FOR was 99.1% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: DAY ONE BIOPHARMACEUTICALS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-05-24.
DAY ONE BIOPHARMACEUTICALS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025.